Phase IB Followed by Phase II Study of Trastuzumab Combined With Autologous T Cells Expressing an Antibody-dependent Cell Cytotoxicity Receptor (ADCC-R) and an Erythropoietin Receptor (Epo-R) in HER2+ Advanced Breast Cancer and Other Solid Tumors
Conditions: HER2+ Advanced Breast Cancer; Other Solid Tumors Interventions: Drug: ADCC-R-Epo-R T-cells + Trastuzumab; Drug: Erythropoietin beta; Drug: Fludarabine and Cyclophosphosphamide Sponsor: National University Hospital, Singapore Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
SINGAPORE and BASEL, Switzerland and SYDNEY, Sept. 5, 2023. ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in multiple therapeutic fields, today announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 5, 2023 Category: Pharmaceuticals Source Type: clinical trials
Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis
Conditions: Peritoneal Dialysis Catheter Exit Site Infection; End Stage Renal Disease on Dialysis; Dialysis; Complications Intervention: Other: Chlorhexidine Gluconate-gel (CHG) Dressing Sponsor: National Healthcare Group, Singapore Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials
